Skip to main content
Top
Published in: Infection 4/2011

01-08-2011 | Images in infection

A case of tuberculous meningitis with multiple intracranial tuberculomas and miliary tuberculosis and choroid tubercles

Authors: K. K. Yasar, F. Pehlivanoglu, G. Sengoz, N. Ayrancioglu

Published in: Infection | Issue 4/2011

Login to get access

Excerpt

A 23-year-old woman, negative for anti-human immunodeficiency virus, was admitted to our hospital with a 15-day history of fever, cough, headache, and convulsion. Physical examination was normal except for left side hypoesthesia. Laboratory findings were within normal range except for C-reactive protein (63 mg/L) and erythrocyte sedimentation rate (52 mm/h). A miliary pattern was detected by high-resolution computed tomography scanning (Fig. 1). Fundoscopic examination revealed bilateral choroid tubercles (Fig. 2). Since multiple intracranial tuberculomas were detected by cranial magnetic resonance imaging (MRI) (Fig. 3), isoniazid, rifampicin, ethambutol, pyrazinamide, and dexamethasone were administered, and antiepileptic therapy was started. Her symptoms disappeared on day 10. Deterioration in the patient’s condition, based on clinical and radiological tests, on month 1, 2, and 4 was considered to be a recurrent paradoxical reaction (PR). The patient was treated with prolonged high-dose steroid therapy and with the same antituberculosis therapeutic regimen. The intracranial nodules disappeared by month 7 (Fig. 4).
Metadata
Title
A case of tuberculous meningitis with multiple intracranial tuberculomas and miliary tuberculosis and choroid tubercles
Authors
K. K. Yasar
F. Pehlivanoglu
G. Sengoz
N. Ayrancioglu
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Infection / Issue 4/2011
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0144-2

Other articles of this Issue 4/2011

Infection 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine